Literature DB >> 6297605

Phosphatidic acid phosphatase activity in subcellular fractions derived from adult rat type II pneumocytes in primary culture.

C A Crecelius, W J Longmore.   

Abstract

The development of a method for the subcellular isolation of lamellar body, microsomal, mitochondrial and cytosolic enriched fractions from the adult rat type II pneumocyte is presented. These fractions were used to investigate the distribution and specificity of phosphatidic acid phosphatase (EC 3.1.3.4). The cytosolic enriched fraction possessed the greatest proportion of total phosphatidic acid phosphatase activity and the highest relative specific activity. The small amounts of phosphatase activity in the lamellar body, microsomal and mitochondrial enriched fractions correlated best with a nonspecific phosphatase activity. 1,2-Disaturated phosphatidic acid served as a slightly better substrate than did 1-saturated, 2-unsaturated phosphatidic acid in the cytosolic enriched fraction. This observation indicates that the de novo pathway could contribute to dipalmitoylphosphatidylcholine synthesis in the rat type II pneumocyte.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297605     DOI: 10.1016/0005-2760(83)90184-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Subcellular sites of synthesis of phosphatidylglycerol and phosphatidylinositol in type II pneumonocytes.

Authors:  J E Bleasdale; N E Tyler; J M Snyder
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  The effects of Triton X-100 and chlorpromazine on the Mg2+-dependent and Mg2+-independent phosphatidate phosphohydrolase activities of rat lung.

Authors:  P A Walton; F Possmayer
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  Molecular species of phosphatidylcholine and phosphatidylglycerol in rat lung surfactant and different pools of pneumocytes type II.

Authors:  M Schlame; C Casals; B Rüstow; H Rabe; D Kunze
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.